Sibutramine - Genesis | 100tabs | 20 mg/tab represents one of the most potent centrally acting weight-management compounds in sports pharmacology. Manufactured under stringent quality assurance by Genesis, this formulation contains 20 mg of pure Sibutramine hydrochloride per tablet, delivering profound appetite suppression and metabolic activation tailored for bodybuilders, strength athletes, and fitness enthusiasts undergoing aggressive caloric deficits.
Sibutramine exerts its action primarily as a combined serotonin-norepinephrine reuptake inhibitor (SNRI). Unlike classic amphetamine-based stimulants that force massive catecholamine release, Sibutramine inhibits the reuptake of norepinephrine, serotonin, and to a lesser extent dopamine at the synaptic cleft. This results in two distinct, synergistic physiological effects:
For athletes looking to retain hard-earned muscle while stripping away stubborn visceral and subcutaneous fat, utilizing high-grade Sibutramine provides the chemical edge needed to maintain strict dietary discipline without debilitating lethargy.
Due to its sustained metabolic half-life, Sibutramine is taken once daily in the morning, with or without food. Peak serum levels are reached within 1 to 2 hours post-administration.
Sibutramine combines exceptionally well with anabolics such as Testosterone Propionate, Drostanolone (Masteron), and Trenbolone Acetate to preserve nitrogen balance while shredding. It can also be stacked alongside non-stimulant metabolic drivers like L-Carnitine and moderate-dose Liothyronine (T3). Caution: Avoid combining high-dose Sibutramine with high-stimulant compounds like ephedrine, excessive caffeine, or yohimbine to prevent excessive cardiovascular strain.
Common side effects stem from sympathetic activation: mild dry mouth, mild insomnia, elevated resting pulse, and transient blood pressure spikes. Users must routinely monitor systolic and diastolic values throughout the cycle. Adequate hydration (3–4 liters of water daily) and electrolyte supplementation are recommended to mitigate xerostomia.
Appetite suppression is generally experienced on the first day of administration, typically within 2 to 4 hours after taking the initial 20 mg dose. Maximum systemic stability is established within 3 to 4 days.
No, taking Sibutramine later in the afternoon or evening is not recommended. Due to its central norepinephrine reuptake inhibition and long half-life, late administration can cause insomnia and sleep fragmentation.
No. Sibutramine is non-hormonal and does not suppress the hypothalamic-pituitary-gonadal (HPG) axis. It does not lower endogenous testosterone production and therefore requires no hormonal PCT protocol.
